Euro Biosimilars Conferences Readership Profiles: Key Metrics (Source: Google Analytics)

A statistical representation of global users for biosimilars-biologics.pharmaceuticalconferences.com/europe(Source: Google Analytics)

Visitor Analysis Report

The dashboard of Google Analytics traffic overview of “16th European Biosimilars Congress” clearly reflects the interests of the global enthusiastic conference attendees like Pharmacists and Pharmacologist, Researchers, Industrialists , Health care professionals, Industrial Experts and Psychiatrist from around the globe who are searching to attend and  present/exhibit  their research/organization findings on highly acknowledged international conferences like ours with the web traffic a total of about 22,114 visits. The total page views were close to 101,004 where our reports are analysed half yearly.
 

  • More than 70000 Visitors visiting conference website to attend and submit proposals Highest number of Visitors reporting both from the developed and developing nations.
  • For Under developing nations researchers our conference website is yardstick to quantify their research proposal submitted
  • Majority of the visitors have come from countries/territories like United States of America, United Kingdom, United Arab Emirates, Brazil, Canada, Mexico, Australia, China, India, Hong Kong, Indonesia, Japan, Malaysia, Thailand, New Zealand, Philippines, Singapore, Taiwan, Thailand, South Korea, Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, Spain, Switzerland, Turkey and Ukraine
  • Highest number of Visitors reporting both from the developed and developing nations.
  • Penetrating the study of visitor, navigation, and traffic patterns to determine the success of our conference website majority amount of traffic we receive from cities like Austin, Boston, Chicago, Dallas, Denver, Houston, Los Angeles, Nashville, New York, Philadelphia, Phoenix, San Antonio, San Diego, Seattle, Washington, Toronto, Montreal, Vancouver, Berlin, Barcelona, Paris, Edinburgh, London, Rome, Valencia, Zurich, Copenhagen, Athens, Moscow, Vienna, Sydney, Melbourne, Beijing, Hyderabad, Tokyo, Singapore, Seoul, Auckland, Cairo, Dubai, Riyadh and Istanbul.
  • Average Time spent by each visitor on Site is over 2.00 Minute.

The Traffic Sources mentions that the number of Unique Visitors of the website listing from academic professionals and medical industries, research organizations, healthcare companies.

Reasons behind listing Euro Biosimilars 2023 top of search engines: (Source: Google)

  • Researchers are inclined only to the conferences where their profiles and abstracts get highest visibility and readership.
  • The most accessible way for researchers to grow their research profiles is through their contributions with a conference presentation at our conference.
  • Our Conference provides opportunities to network and meet other researchers in their field and establish potential contacts for future positions.
  • Attending and presenting at our conference would contribute to learn about the most recent advances in their field.
  • Get an opportunity to publish full paper in our international journals with high impact factors on Special issues.

Besides all these factors we also create individual speaker pages where their accepted biographies and abstracts are updated on regular basis for promoting their web presence in all the search engine listings and Social Networking Channels.

With 10 years now added to its repertoire, European Biosimilars Congress is really turning into a staple meeting where Biosimilars partners accumulate to address the present and future condition of Biosimilars in the Europe.

The expansion of two devoted streams for the European Biosimilars Congress meeting was a hit – we could pick up knowledge from two particular groups – one that exceeded expectations in the systematic and assembling end – and one that exceeded expectations in the business and key end.

The 2022 establishment of this meeting will enable us to keep on diving further into both the investigation of Biosimilars improvement – and the business requirements for organizations that keep on seeking FDA endorsement.

The Organizing Committee is delighted to invite you to attend the  Euro Biosimilars one of its remarkable Pharmaceutical conferences, to be held during April 03-04, 2023 at Barcelona, SpainEuropean Biosimilars Congress is a global annual event. This European Biosimilars Congress 2023 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

At Euro Bisimilars 2023 meet your target audiences from around the world focused on learning about biologics and Biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and Biosimilars community.

2022 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 10+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Motives to attend:

  • Keynote presentation along with interactions to galvanize the scientific community.
  • Workshop and symposiums to reach the largest assemblage of participants from the Pharma/Biotech community.
  • A wide track of exhibitors to showcase the new and emerging technologies.
  • Platform to global investment community to connect with stakeholders in Pharma/Biotech sector.
  • Young Scientist/ Investigators Award geared towards best budding young research.
  • Links to the political marketing resources in order to expand your business and research network.
  • Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Euro Biosimilars 2023 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Biosimilars & Biologics, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Bioanalysis and Biomedicine International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Euro Biosimilars 2023 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Euro Biosimilars 2023 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Target Audience:

  • Directors, CEO’s of Organizations
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Bioslogics Industries
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Patent Attorneys
  • Intellectual Property Attorneys
  • Investment Analysts
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs

Young Scientist Benefits

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Global Internet users for conferenceseries.com: Statistical representation (Source: Google Analytics)

Flip on the other side Conferenceseries  world’s leading specialist in organizing scientific conferences, events trade, and consumer exhibitions both domestically and internationally in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business attracting more than 25 Million+ Visitors, 25000+ unique visitors per conference and 70000+ page views for every individual conference would help in quantifying our presenters research and biography visibility to the online communities and get recognized worldwide.

Conference Series Web Metrics at Glance: Source: Google Analytics

  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Out of the 500,000 listing worldwide major conferences attended by 2.5 million attendees 16.8% attendees are drawing only from our Medical, Pharma, Healthcare, Nursing, Engineering, Science, Technology and Business conferences. The main reasons behind the increased popularity of our conference attendees is because of the changing mindsets of academicians, researchers and industries in exploring the opportunities for exchanging ideas, sharing resources, building networks and increase awareness of the on the recent happenings in their research around the world.

“Attending and presenting at conferences remains as the most favorable model of knowledge dissemination for researchers and practitioners to keep abreast of all advances in their field, presenting state-of-the-art research usually on a variety of subjects”

We will continue to set our bar higher and make further progress to organize 1000 conferences in 50 countries across all continents by 2018. We have recently launched online digital video library where all our conference proceedings would be shared and be accessed by the online communities freely.

Channels for driving additional traffic to your research

Web Analytics are best means of measuring concrete details like how many people are visiting our websites, how many of those visitors are the unique visitors and how many of them are staying long to view the complete information available in our sites. The following snapshots of some of our websites will clearly depict the metrics how our conferences stand at par to the other conferences in terms of Visibility, outreach, Participation Number and relevance to their subject.

The metrics of these websites represents more than 25+ Million visitors in addition to this we also equipped with 10 additional scientific websites represents 10+ Million visitors traffic to our conference websites.

A statistical representation of global users for www.omicsonline.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.omicsonline.com (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.esciencecentral.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.scitechnol.com (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.omicsgroup.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.conferenceseries.com (Source: Google Analytics)

Visitor Analysis Report